Edaravone/(+)-2-Decanol (Yantai Yene/Simcere)

依达拉奉右莰醇 (烟台益诺依生物/先声药业)

Report date: 2025/03/17 09:59:30

Base Information

Drug NameEdaravone/(+)-2-Decanol (Yantai Yene/Simcere)
Drug Alias NameY-2舌下片依达拉奉右莰醇舌下片依达拉奉右莰醇口服改良型 (烟台益诺依生物/先声药业)Y-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengersTumor necrosis factor α inhibitorsInterleukin-1 beta inhibitors +[5] 
TargetsFree radicalsTumor necrosis factor αInterleukin-1 beta +[5] 
Therapy Area/IndicationsIschemic StrokeCognitive DysfunctionStroke +[5] 
Global Approved IndicationsStroke
Approved Indications in ChinaStroke
Original Approved Country/TerritoryMainland China
Original Approved Date2024/12/01
Country/TerritoryUnited StatesMainland China
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYantai Yene Pharma Co LtdSimcere Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSimcere Pharmaceutical Co LtdJiangsu Simcere Pharmaceutical Co LtdNanjing Simcere Dongyuan Pharmaceutical Co Ltd +[4] 
Inactive Companies2y-Biopharma +[2] 
Active IndicationsIschemic StrokeCognitive DysfunctionStroke +[4] 
Inactive IndicationsIntracranial Hemorrhages

Other Information

ATC CodeN/A
Related LinksN/A